Defending transparency at European drug regulator

8 January 2020 - Forthcoming judgment must uphold public access to clinical data ...

Read more →

Price disclosure 2020 April cycle outcomes summary

18 December 2019 - The summary of price disclosure price reductions for the 2020 April Cycle has now been published. ...

Read more →

Hospital groups sue to block price transparency rule

4 December 2019 - Health care providers say disclosure requirement pushed by Trump violates First Amendment. ...

Read more →

How to navigate specialist fees in the private health system

26 November 2019 - Have you ever taken up private health insurance, only to end up hundreds or thousands of ...

Read more →

Transparency is a first step in bringing down drug costs for American seniors, families

21 November 2019 - Wherever I go — be it to school events, county fairs, town halls, or even the ...

Read more →

To lower costs, Trump to force hospitals to reveal price of care

15 November 2019 - The Trump administration on Friday announced it would begin forcing hospitals to publicly disclose the discounted ...

Read more →

Improving transparency in decision models: current issues and potential solutions

23 October 2019 - Decision-analytic models have become an essential tool used to inform health technology assessments. ...

Read more →

NICE, in confidence: an assessment of redaction to obscure confidential information in single technology appraisals by the National Institute for Health and Care Excellence

17 November 2019 - Health technology assessment aims to provide a transparent framework within which normative judgements can be applied for ...

Read more →

Canada's decision to make public more clinical trial data puts pressure on FDA

11 October 2019 - Last March, Canada's department of health changed the way it handles the huge amount of data ...

Read more →

Why transparency in drug pricing is more complicated than it seems

1 October 2019 - Transparency has become a prominent topic in debates about health care, particularly when it comes to ...

Read more →

1 October 2019 price disclosure confirmed prices

30 September 2019 - Confirmed 1 October 2019 prices resulting from the 2019 October Cycle of Price Disclosure have now been ...

Read more →

Achieving appropriate model transparency: challenges and potential solutions for making value‑based decisions in the United States

5 September 2019 - Transparency in decision modeling remains a topic of rigorous debate among healthcare stakeholders, given tensions between the ...

Read more →

What is the value of market-wide health care price transparency?

5 September 2019 - A primary driver of high spending in the US health care system, relative to other countries, ...

Read more →

Capital Rx to inject transparency in prescription drug prices

4 September 2019 - In recent years, the pharmacy benefits management industry's pricing practices have been under intense scrutiny by ...

Read more →

Time for FDA to release complete responses letters? Debate reignites.

23 August 2019 - The idea of the US FDA releasing complete response letters resurfaced this week as Sarepta Therapeutics ...

Read more →